{"id":394,"date":"2012-07-29T11:13:29","date_gmt":"2012-07-29T11:13:29","guid":{"rendered":"http:\/\/rdg-cro.com\/?page_id=394"},"modified":"2012-09-16T16:40:18","modified_gmt":"2012-09-16T16:40:18","slug":"development-of-generics","status":"publish","type":"page","link":"http:\/\/rdg-cro.com\/?page_id=394&lang=en","title":{"rendered":"Development of generics"},"content":{"rendered":"<p><strong>Creation of generic drug equivalent to the selected analog<\/strong><\/p>\n<ul>\n<li>We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 development costs, and all types of studies.<\/li>\n<li>We determine the optimal dosage form<\/li>\n<li>We conduct: preclinical, toxicity and pharmacology studies in animals, bioequivalence studies, bioavailability assessment<\/li>\n<li>We develop and validate methods of analysis of generic drug for normative documentation and for bioequivalence studies in clinical practice<\/li>\n<li>We develop normative documentation (ND, experimental and industrial standing orders)<\/li>\n<li>We implement pilot manufacturing for laboratory examination and clinical studies<\/li>\n<\/ul>\n<p>In the development of innovative drug during formulation research, the pharmacokinetic profile of the future drug is determined.<br \/>\nIn the course of development it is possible to create any dosage forms.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Creation of generic drug equivalent<a href=\"http:\/\/rdg-cro.com\/?page_id=394&#038;lang=en\"> \u043f\u043e\u0434\u0440\u043e\u0431\u043d\u0435\u0435&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":252,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","meta":{"footnotes":""},"class_list":["post-394","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"http:\/\/rdg-cro.com\/?page_id=394&#038;lang=en\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"ru_RU\" \/>\n\t\t<meta property=\"og:site_name\" content=\"R&amp;D Group -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Development of generics - R&amp;D Group\" \/>\n\t\t<meta property=\"og:description\" content=\"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology\" \/>\n\t\t<meta property=\"og:url\" content=\"http:\/\/rdg-cro.com\/?page_id=394&#038;lang=en\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2012-07-29T11:13:29+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2012-09-16T16:40:18+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Development of generics - R&amp;D Group\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=394&lang=en#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/rdg-cro.com\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=252&lang=en#listItem\",\"name\":\"Drug development\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=252&lang=en#listItem\",\"position\":2,\"name\":\"Drug development\",\"item\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=252&lang=en\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=394&lang=en#listItem\",\"name\":\"Development of generics\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=394&lang=en#listItem\",\"position\":3,\"name\":\"Development of generics\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=252&lang=en#listItem\",\"name\":\"Drug development\"}}]},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/#organization\",\"name\":\"R&D Group\",\"url\":\"http:\\\/\\\/rdg-cro.com\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=394&lang=en#webpage\",\"url\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=394&lang=en\",\"name\":\"Development of generics - R&D Group\",\"description\":\"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology\",\"inLanguage\":\"ru-RU\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/?page_id=394&lang=en#breadcrumblist\"},\"datePublished\":\"2012-07-29T11:13:29+00:00\",\"dateModified\":\"2012-09-16T16:40:18+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/#website\",\"url\":\"http:\\\/\\\/rdg-cro.com\\\/\",\"name\":\"R&D Group\",\"inLanguage\":\"ru-RU\",\"publisher\":{\"@id\":\"http:\\\/\\\/rdg-cro.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Development of generics - R&D Group","description":"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology","canonical_url":"http:\/\/rdg-cro.com\/?page_id=394&lang=en","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"http:\/\/rdg-cro.com\/?page_id=394&lang=en#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"http:\/\/rdg-cro.com\/#listItem","position":1,"name":"Home","item":"http:\/\/rdg-cro.com\/","nextItem":{"@type":"ListItem","@id":"http:\/\/rdg-cro.com\/?page_id=252&lang=en#listItem","name":"Drug development"}},{"@type":"ListItem","@id":"http:\/\/rdg-cro.com\/?page_id=252&lang=en#listItem","position":2,"name":"Drug development","item":"http:\/\/rdg-cro.com\/?page_id=252&lang=en","nextItem":{"@type":"ListItem","@id":"http:\/\/rdg-cro.com\/?page_id=394&lang=en#listItem","name":"Development of generics"},"previousItem":{"@type":"ListItem","@id":"http:\/\/rdg-cro.com\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"http:\/\/rdg-cro.com\/?page_id=394&lang=en#listItem","position":3,"name":"Development of generics","previousItem":{"@type":"ListItem","@id":"http:\/\/rdg-cro.com\/?page_id=252&lang=en#listItem","name":"Drug development"}}]},{"@type":"Organization","@id":"http:\/\/rdg-cro.com\/#organization","name":"R&D Group","url":"http:\/\/rdg-cro.com\/"},{"@type":"WebPage","@id":"http:\/\/rdg-cro.com\/?page_id=394&lang=en#webpage","url":"http:\/\/rdg-cro.com\/?page_id=394&lang=en","name":"Development of generics - R&D Group","description":"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology","inLanguage":"ru-RU","isPartOf":{"@id":"http:\/\/rdg-cro.com\/#website"},"breadcrumb":{"@id":"http:\/\/rdg-cro.com\/?page_id=394&lang=en#breadcrumblist"},"datePublished":"2012-07-29T11:13:29+00:00","dateModified":"2012-09-16T16:40:18+00:00"},{"@type":"WebSite","@id":"http:\/\/rdg-cro.com\/#website","url":"http:\/\/rdg-cro.com\/","name":"R&D Group","inLanguage":"ru-RU","publisher":{"@id":"http:\/\/rdg-cro.com\/#organization"}}]},"og:locale":"ru_RU","og:site_name":"R&amp;D Group -","og:type":"article","og:title":"Development of generics - R&amp;D Group","og:description":"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology","og:url":"http:\/\/rdg-cro.com\/?page_id=394&#038;lang=en","article:published_time":"2012-07-29T11:13:29+00:00","article:modified_time":"2012-09-16T16:40:18+00:00","twitter:card":"summary_large_image","twitter:title":"Development of generics - R&amp;D Group","twitter:description":"Creation of generic drug equivalent to the selected analog We select the generic drug based on the characteristics of manufacturing, state registration, scale of required preclinical and clinical studies taking into account the minimization of development costs, and all types of studies. We determine the optimal dosage form We conduct: preclinical, toxicity and pharmacology"},"aioseo_meta_data":{"post_id":"394","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-27 05:57:25","updated":"2026-10-28 09:01:21"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"http:\/\/rdg-cro.com\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"http:\/\/rdg-cro.com\/?page_id=252&amp;lang=en\" title=\"Drug development\">Drug development<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tDevelopment of generics\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"http:\/\/rdg-cro.com\/"},{"label":"Drug development","link":"http:\/\/rdg-cro.com\/?page_id=252&lang=en"},{"label":"Development of generics","link":"http:\/\/rdg-cro.com\/?page_id=394&lang=en"}],"_links":{"self":[{"href":"http:\/\/rdg-cro.com\/index.php?rest_route=\/wp\/v2\/pages\/394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/rdg-cro.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/rdg-cro.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/rdg-cro.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/rdg-cro.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=394"}],"version-history":[{"count":2,"href":"http:\/\/rdg-cro.com\/index.php?rest_route=\/wp\/v2\/pages\/394\/revisions"}],"predecessor-version":[{"id":1061,"href":"http:\/\/rdg-cro.com\/index.php?rest_route=\/wp\/v2\/pages\/394\/revisions\/1061"}],"up":[{"embeddable":true,"href":"http:\/\/rdg-cro.com\/index.php?rest_route=\/wp\/v2\/pages\/252"}],"wp:attachment":[{"href":"http:\/\/rdg-cro.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}